Integrated Diagnostics
Why: By reducing the cost of diagnostic tests, it has allowed the monitoring of more disease markers.
Key innovation: Its synthetic antibodies replace more expensive antibodies widely used in diagnostics.
Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?